Cargando…
Source, co-occurrence, and prognostic value of PTEN mutations or loss in colorectal cancer
Somatic PTEN mutations are common and have driver function in some cancer types. However, in colorectal cancers (CRCs), somatic PTEN-inactivating mutations occur at a low frequency (~8–9%), and whether these mutations are actively selected and promote tumor aggressiveness has been controversial. Ana...
Autores principales: | Serebriiskii, Ilya G., Pavlov, Valerii A., Andrianov, Grigorii V., Litwin, Samuel, Basickes, Stanley, Newberg, Justin Y., Frampton, Garrett M., Meyer, Joshua E., Golemis, Erica A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10674024/ https://www.ncbi.nlm.nih.gov/pubmed/38001126 http://dx.doi.org/10.1038/s41525-023-00384-7 |
Ejemplares similares
-
Comprehensive characterization of PTEN mutational profile in a series of 34,129 colorectal cancers
por: Serebriiskii, Ilya G., et al.
Publicado: (2022) -
Comprehensive characterization of RAS mutations in colon and rectal cancers in old and young patients
por: Serebriiskii, Ilya G., et al.
Publicado: (2019) -
A gene expression system offering multiple levels of regulation: the Dual Drug Control (DDC) system
por: Sudomoina, Marina, et al.
Publicado: (2004) -
Identification of evolutionarily conserved DNA damage response genes that alter sensitivity to cisplatin
por: Gaponova, Anna V., et al.
Publicado: (2016) -
Combined inhibition of Aurora A and p21-activated kinase 1 as a new treatment strategy in breast cancer
por: Korobeynikov, Vladislav, et al.
Publicado: (2019)